• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Healthy Returns

Recent news which mentions Healthy Returns

Healthy Returns: Wegovy may reduce knee pain in patients with a type of arthritis and obesity
October 31, 2024
Tags Health & Science Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Healthy Returns: Weight loss, diabetes drugs may reduce alcohol and opioid use
October 23, 2024
Tags Health care industry Science Microsoft Corp
From CNBC.com News
Healthy Returns: Covering weight loss drugs could cost Medicare $35 billion through 2034
October 15, 2024
Tags Health care industry Healthy Returns LILLY DRN
From CNBC.com News
Healthy Returns: What activist Starboard's $1 billion stake means for Pfizer
October 08, 2024
Tags Hims & Hers Health Inc Health & Science Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: Pfizer pulls sickle cell disease drug from markets – here’s why it matters
October 01, 2024
Tags Pfizer Inc Biotech and Pharmaceuticals UnitedHealth Group Inc
From CNBC.com News
Healthy Returns: Weight loss drug Wegovy could face Medicare price negotiations next
September 24, 2024
Tags Health & Science Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Healthy Returns: How competitive can Roche be in the weight loss drug market?
September 17, 2024
Tags Healthy Returns Roche Holding AG Eli Lilly and Co
From CNBC.com News
Healthy Returns: More than 50 million privately insured adults could be eligible for GLP-1 drugs
September 10, 2024
Tags Social issues Health & Science Novo Nordisk A/S
From CNBC.com News
Healthy Returns: Eli Lilly could soon become the first $1 trillion health-care stock
September 05, 2024
Tags Social issues Abbott Laboratories Berkshire Hathaway Inc
From CNBC.com News
Healthy Returns: What to know about the latest round of Pfizer, Moderna Covid vaccines
August 27, 2024
Tags Novavax Inc Health & Science Pfizer Inc
From CNBC.com News
Healthy Returns: The race to develop combination shots targeting Covid, flu is heating up
August 20, 2024
Tags BioNTech SE Moderna Inc Social issues
From CNBC.com News
Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market
August 14, 2024
Tags Healthy Returns Health care industry Eli Lilly and Co
From CNBC.com News
Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare
August 06, 2024
Tags Health care industry Novartis AG Johnson & Johnson
From CNBC.com News
Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes
July 31, 2024
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Health & Science
From CNBC.com News
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
July 23, 2024
Tags Healthy Returns Novartis AG Health care industry
From CNBC.com News
Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use
July 16, 2024
Tags Health & Science Merck & Co Inc Pfizer Inc
From CNBC.com News
Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills
July 11, 2024
Tags Healthy Returns Eli Lilly and Co Health care industry
From CNBC.com News
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
July 03, 2024
Tags Health & Science Altimmune Inc Gilead Sciences Inc
From CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
June 26, 2024
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Zealand Pharma A/S
From CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
June 18, 2024
Tags Healthy Returns Eli Lilly and Co Health care industry
From CNBC.com News
Healthy Returns: What we know about the next round of Covid vaccines
June 12, 2024
Tags Healthy Returns Microsoft Corp Alphabet Inc
From CNBC.com News
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
June 07, 2024
Tags AstraZeneca PLC Moderna Inc Health & Science
From CNBC.com News
Healthy Returns: Pfizer, Merck, J&J and more to release cancer drug data at industry conference
May 30, 2024
Tags Biotech and Pharmaceuticals Pfizer Inc Merck & Co Inc
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
May 21, 2024
Tags Health & Science Uber Technologies Inc Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says
May 14, 2024
Tags Health & Science Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply
May 07, 2024
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Health & Science
From CNBC.com News
Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors
May 01, 2024
Tags Healthy Returns Abbvie Inc CVS Health Corp
From CNBC.com News
Healthy Returns: Biotech IPOs ramped up to start 2024, but the market hasn't fully recovered just yet
April 23, 2024
Tags Fractyl Health Inc Chromocell Therapeutics Corp Health & Science
From CNBC.com News
Healthy Returns: U.S. drug shortages reach record high, hitting Wegovy, ADHD medications
April 16, 2024
Tags Healthy Returns Health care industry Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: J&J cell therapy gains new edge over Bristol Myers rival
April 09, 2024
Tags Johnson & Johnson Health care industry Science
From CNBC.com News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap